This compound is a pharmaceutical intermediate used in the production of kinase inhibitors, including baricitinib. It acts as a JAK1 and JAK2 inhibitor, relevant for research into immunomodulatory therapies.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1187594-13-3
(4-(1-(3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate
Pharmaceutical intermediate for baricitinib synthesis
2-Bromo-5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazine
Pharmaceutical intermediate for kinase inhibitors
2,4-dichloro-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine
Pharmaceutical intermediate for kinase inhibitors
Tert-Butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
Pharmaceutical intermediate for kinase inhibitors
1-(benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine
Pharmaceutical intermediate for kinase inhibitors
4-(Dimethylamino)but-2-ynoic acid hydrochloride
intermediate for afatinib synthesis
6-CHLOROQUINOLINE-3-CARBOXYLIC ACID
Pharmaceutical intermediate
(R)-2-Aminomethyl-1-N-Cbz-pyrrolidine
Pharmaceutical intermediate
2-[1-ethylsulfonyl-3-[4-[7-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-d]pyrimidin-4-yl]pyrazol-1-yl]azetidin-3-yl]acetonitrile
WUWJJJDMZWZKQS-UHFFFAOYSA-N
CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CN(C4=NC=N3)COCC[Si](C)(C)C
—